BRIEF-AstraZeneca, Ironwood agree U.S. licensing agreement

* Agreement includes U.S. rights to zurampic and lesinurad/allopurinol fixed-dose combination in gout
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.